Géraldine Cizeron-Clairac

1.4k total citations
16 papers, 1.1k citations indexed

About

Géraldine Cizeron-Clairac is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Géraldine Cizeron-Clairac has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Oncology. Recurrent topics in Géraldine Cizeron-Clairac's work include Myasthenia Gravis and Thymoma (7 papers), Pituitary Gland Disorders and Treatments (4 papers) and Circular RNAs in diseases (3 papers). Géraldine Cizeron-Clairac is often cited by papers focused on Myasthenia Gravis and Thymoma (7 papers), Pituitary Gland Disorders and Treatments (4 papers) and Circular RNAs in diseases (3 papers). Géraldine Cizeron-Clairac collaborates with scholars based in France, Czechia and Israel. Géraldine Cizeron-Clairac's co-authors include Rozen Le Panse, Sonia Berrih‐Aknin, Jacky Bismuth, Rosette Lidereau, Sophie Vacher, Ivan Bièche, A. Susini, Frédérique Truffault, Catherine Andrieu and Magdalena Čížková and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Géraldine Cizeron-Clairac

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Cizeron-Clairac France 16 472 343 340 202 176 16 1.1k
George Vlotides Germany 15 295 0.6× 135 0.4× 88 0.3× 234 1.2× 156 0.9× 25 863
Arunkumar B. Deora United States 10 760 1.6× 364 1.1× 87 0.3× 53 0.3× 215 1.2× 12 1.1k
W. Lutz Germany 18 833 1.8× 312 0.9× 538 1.6× 211 1.0× 140 0.8× 27 1.3k
Lynn Ogata United States 7 216 0.5× 247 0.7× 112 0.3× 146 0.7× 913 5.2× 8 1.2k
Heather M. Shaw United Kingdom 13 349 0.7× 116 0.3× 39 0.1× 352 1.7× 93 0.5× 34 725
Kumiko Goi Japan 21 665 1.4× 178 0.5× 40 0.1× 356 1.8× 191 1.1× 78 1.2k
Obul Reddy Bandapalli Germany 19 501 1.1× 221 0.6× 29 0.1× 401 2.0× 340 1.9× 47 1.3k
Mark N. Jabbour Lebanon 18 230 0.5× 135 0.4× 78 0.2× 164 0.8× 55 0.3× 36 670
Gordon T. Sakamoto United States 15 323 0.7× 109 0.3× 288 0.8× 174 0.9× 35 0.2× 20 965
Yuko Nagamura Japan 12 289 0.6× 75 0.2× 84 0.2× 216 1.1× 469 2.7× 20 935

Countries citing papers authored by Géraldine Cizeron-Clairac

Since Specialization
Citations

This map shows the geographic impact of Géraldine Cizeron-Clairac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Cizeron-Clairac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Cizeron-Clairac more than expected).

Fields of papers citing papers by Géraldine Cizeron-Clairac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Cizeron-Clairac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Cizeron-Clairac. The network helps show where Géraldine Cizeron-Clairac may publish in the future.

Co-authorship network of co-authors of Géraldine Cizeron-Clairac

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Cizeron-Clairac. A scholar is included among the top collaborators of Géraldine Cizeron-Clairac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Cizeron-Clairac. Géraldine Cizeron-Clairac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dragin, Nadine, Jacky Bismuth, Géraldine Cizeron-Clairac, et al.. (2016). Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases. Journal of Clinical Investigation. 126(4). 1525–1537. 148 indexed citations
2.
Cizeron-Clairac, Géraldine, François Lallemand, Sophie Vacher, et al.. (2015). MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?. BMC Cancer. 15(1). 499–499. 46 indexed citations
3.
Lerebours, Florence, Géraldine Cizeron-Clairac, A. Susini, et al.. (2013). miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness. International Journal of Cancer. 133(7). 1614–1623. 62 indexed citations
4.
Pignot, G., Géraldine Cizeron-Clairac, Sophie Vacher, et al.. (2012). microRNA expression profile in a large series of bladder tumors: Identification of a 3‐miRNA signature associated with aggressiveness of muscle‐invasive bladder cancer. International Journal of Cancer. 132(11). 2479–2491. 152 indexed citations
5.
Čížková, Magdalena, A. Susini, Sophie Vacher, et al.. (2012). PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups. Breast Cancer Research. 14(1). R28–R28. 143 indexed citations
6.
Vacher, Sophie, A. Susini, Géraldine Cizeron-Clairac, et al.. (2012). Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer. Genes & Cancer. 3(1). 63–70. 26 indexed citations
7.
Bièche, Ivan, Sophie Vacher, François Lallemand, et al.. (2011). Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy. Molecular Cancer. 10(1). 23–23. 58 indexed citations
8.
Panse, Rozen Le, Jacky Bismuth, Géraldine Cizeron-Clairac, et al.. (2010). Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity. 43(5-6). 401–412. 62 indexed citations
9.
Čížková, Magdalena, Géraldine Cizeron-Clairac, Sophie Vacher, et al.. (2010). Gene Expression Profiling Reveals New Aspects of PIK3CA Mutation in ERalpha-Positive Breast Cancer: Major Implication of the Wnt Signaling Pathway. PLoS ONE. 5(12). e15647–e15647. 54 indexed citations
10.
Scodan, Romuald Le, Géraldine Cizeron-Clairac, Emmanuelle Fourme, et al.. (2010). DNA Repair Gene Expression and Risk of Locoregional Relapse in Breast Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 78(2). 328–336. 30 indexed citations
11.
Berrih‐Aknin, Sonia, Jacky Bismuth, Géraldine Cizeron-Clairac, et al.. (2009). CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Annals of Neurology. 66(4). 521–531. 59 indexed citations
12.
Panse, Rozen Le, Géraldine Cizeron-Clairac, Frédérique Truffault, et al.. (2008). Regulatory and Pathogenic Mechanisms in Human Autoimmune Myasthenia Gravis. Annals of the New York Academy of Sciences. 1132(1). 135–142. 46 indexed citations
13.
Cizeron-Clairac, Géraldine, Rozen Le Panse, Frédérique Truffault, et al.. (2008). Thymus and Myasthenia Gravis: What can we learn from DNA microarrays?. Journal of Neuroimmunology. 201-202. 57–63. 23 indexed citations
14.
Gilboa-Geffen, Adi, Lilach Soreq, Géraldine Cizeron-Clairac, et al.. (2007). The thymic theme of acetylcholinesterase splice variants in myasthenia gravis. Blood. 109(10). 4383–4391. 29 indexed citations
15.
Panse, Rozen Le, Géraldine Cizeron-Clairac, Jacky Bismuth, & Sonia Berrih‐Aknin. (2006). Microarrays Reveal Distinct Gene Signatures in the Thymus of Seropositive and Seronegative Myasthenia Gravis Patients and the Role of CC Chemokine Ligand 21 in Thymic Hyperplasia. The Journal of Immunology. 177(11). 7868–7879. 58 indexed citations
16.
Cizeron-Clairac, Géraldine, Rozen Le Panse, Jacky Bismuth, et al.. (2006). The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. 108(2). 432–440. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Vlotides Breakdown of academic impact, for papers by Arunkumar B. Deora Breakdown of academic impact, for papers by W. Lutz Breakdown of academic impact, for papers by Lynn Ogata Breakdown of academic impact, for papers by Heather M. Shaw Breakdown of academic impact, for papers by Kumiko Goi Breakdown of academic impact, for papers by Obul Reddy Bandapalli Breakdown of academic impact, for papers by Mark N. Jabbour Breakdown of academic impact, for papers by Gordon T. Sakamoto Breakdown of academic impact, for papers by Yuko Nagamura
Rankless by CCL
2026